Today, Monday, Emirati astronaut Sultan Al Neyadi revealed the details of one of the experiments assigned to him at the International Space Station. Al-Neyadi said, on his official Twitter account, that one of the experiments entrusted to him is the "Cardinal Heart 2.0" study of Stanford University.
He added, "Through this experiment, we can learn about the effects of clinical drugs on heart cells in space, helping to prevent the risk of heart disease for astronauts." He pointed out that this experience will also contribute to the development of treatment for heart disease on Earth.
And the US space agency "NASA" says, "The human heart on the International Space Station is high on the list of concerns ... where diseases or other factors such as aging that affect the heart can change a person's general health and well-being."
The Emirati astronaut, accompanied by the Crew-6 mission crew, successfully launched to the International Space Station a few days ago. Al-Neyadi will undertake the longest scientific mission for the Arabs in space, which will last for six continuous months at the space station. He will participate in scientific experiments in ten vital areas throughout the duration of the mission.
0 Comments